Search research articles
Contact Us
Filters
Showing results (1-10 of 24) with videos related to
Page
of 3
Sort By:
Cells
|
July 2, 2020
Kynurenines in the Pathogenesis of Multiple Sclerosis: Therapeutic Perspectives
Tamás Biernacki, Dániel Sandi, Krisztina Bencsik, et al.
Ideggyogyaszati Szemle
|
June 6, 2018
[Alemtuzumab therapy 2017]
Tamás Biernacki, Krisztina Bencsik, Dániel Sandi, et al.
Mini Reviews in Medicinal Chemistry
|
October 24, 2019
Medicinal Chemistry of Multiple Sclerosis: Focus on Cladribine
Tamás Biernacki, Dániel Sandi, Krisztina Bencsik, et al.
Molecules (Basel, Switzerland)
|
July 2, 2021
Neurodegeneration in Multiple Sclerosis: Symptoms of Silent Progression, Biomarkers and Neuroprotective Therapy-Kynurenines Are Important Players
Dániel Sandi, Zsanett Fricska-Nagy, Krisztina Bencsik, et al.
International Journal of Molecular Sciences
|
May 14, 2022
Proteomics in Multiple Sclerosis: The Perspective of the Clinician
Dániel Sandi, Zsófia Kokas, Tamás Biernacki, et al.
Ideggyogyaszati Szemle
|
June 3, 2024
[A race against time: POEMS syndrome]
Benedek Rónaszéki, Dániel Sandi, Ádám Ónodi, et al.
Ideggyogyaszati Szemle
|
June 6, 2018
[The Multiple Sclerosis Registry of Szeged]
Krisztina Bencsik, Dániel Sandi, Tamás Biernacki, et al.
Ideggyogyaszati Szemle
|
June 6, 2018
[Change of therapeutic algorithm in sclerosis multiplex based on two case reports]
Tamás Biernacki, Krisztina Bencsik, Zsigmond Tamás Kincses, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
May 8, 2018
Pediatric multiple sclerosis and fulminant disease course: Features and approaches to treatment - A case report and review of the literature
Dániel Sandi, Edit Bereg, Tamás Biernacki, et al.
Brain and Behavior
|
November 12, 2019
Contributing factors to health-related quality of life in multiple sclerosis
Tamás Biernacki, Dániel Sandi, Zsigmond Tamás Kincses, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 24) with videos related to
Sort By:
Page
of 3
Cells
|
July 2, 2020
Kynurenines in the Pathogenesis of Multiple Sclerosis: Therapeutic Perspectives
Tamás Biernacki, Dániel Sandi, Krisztina Bencsik, et al.
Ideggyogyaszati Szemle
|
June 6, 2018
[Alemtuzumab therapy 2017]
Tamás Biernacki, Krisztina Bencsik, Dániel Sandi, et al.
Mini Reviews in Medicinal Chemistry
|
October 24, 2019
Medicinal Chemistry of Multiple Sclerosis: Focus on Cladribine
Tamás Biernacki, Dániel Sandi, Krisztina Bencsik, et al.
Molecules (Basel, Switzerland)
|
July 2, 2021
Neurodegeneration in Multiple Sclerosis: Symptoms of Silent Progression, Biomarkers and Neuroprotective Therapy-Kynurenines Are Important Players
Dániel Sandi, Zsanett Fricska-Nagy, Krisztina Bencsik, et al.
International Journal of Molecular Sciences
|
May 14, 2022
Proteomics in Multiple Sclerosis: The Perspective of the Clinician
Dániel Sandi, Zsófia Kokas, Tamás Biernacki, et al.
Ideggyogyaszati Szemle
|
June 3, 2024
[A race against time: POEMS syndrome]
Benedek Rónaszéki, Dániel Sandi, Ádám Ónodi, et al.
Ideggyogyaszati Szemle
|
June 6, 2018
[The Multiple Sclerosis Registry of Szeged]
Krisztina Bencsik, Dániel Sandi, Tamás Biernacki, et al.
Ideggyogyaszati Szemle
|
June 6, 2018
[Change of therapeutic algorithm in sclerosis multiplex based on two case reports]
Tamás Biernacki, Krisztina Bencsik, Zsigmond Tamás Kincses, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
May 8, 2018
Pediatric multiple sclerosis and fulminant disease course: Features and approaches to treatment - A case report and review of the literature
Dániel Sandi, Edit Bereg, Tamás Biernacki, et al.
Brain and Behavior
|
November 12, 2019
Contributing factors to health-related quality of life in multiple sclerosis
Tamás Biernacki, Dániel Sandi, Zsigmond Tamás Kincses, et al.
Page
of 3